Amgen profit tops analysts’ estimates on drug sales, tax credit
Amgen, the nation’s biggest biotech company, reported fourth-quarter profits that beat analysts’ estimates, aided by a tax benefit and higher-than-estimated sales of arthritis drug Enbrel.
Health-care giants tangle over emergency room billing
In its suit, filed Nov. 12, Sierra Vista Hospital says that Oakland-based Kaiser Foundation Health Plan owes it thousands of dollars for treating patients who showed up at its emergency room and were treated.
Spinal fusion kit is latest innovation from ECA Medical
ECA Medical Instruments, a designer and manufacturer of single-procedure torque-limiting surgical kits and other medical devices, is producing the world’s first single-procedure spinal fusion kit.
Getting a grip on diabetes: Aptitude device gets fast track status for clinical trials
Aptitude creates a special type of molecule called an aptamer, which it is using to develop a first-of-its-kind hand-held device that measures insulin concentrations in real-time and can diagnose pre-diabetes. The government’s interest in furthering such research is unsurprising as diabetes affects more than 9 percent of Americans.
